Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Howlader N, Noone AM, Krapcho M, et al. Cancer Statistics Review, 1975–2018—SEER Statistics. SEER Cancer Statistics Review, 1975–2018. https://seer.cancer.gov/csr/1975_2018/. Published 2021. (Accessed 21 February 2022).

  2. von Waldenfels G, Loibl S, Furlanetto J, et al. Outcome after neoadjuvant chemotherapy in elderly breast cancer patients—a pooled analysis of individual patient data from eight prospectively randomized controlled trials. Oncotarget. 2018;9(20):15168–79.

    Article  Google Scholar 

  3. Williams AD, Dang CT, Sevilimedu V, Morrow M, Barrio AV. Neoadjuvant chemotherapy for breast cancer in the elderly: are we accomplishing our treatment goals? Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12206-8.

  4. Kalinsky K, Barlow WE, Gralow JR, et al. 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Austin D. Williams MD, MSEd & Andrea V. Barrio MD

Authors
  1. Austin D. Williams MD, MSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea V. Barrio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea V. Barrio MD.

Ethics declarations

Disclosures

The authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, A.D., Barrio, A.V. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer. Ann Surg Oncol 29, 8012–8013 (2022). https://doi.org/10.1245/s10434-022-12324-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12324-3

Search

Navigation